TW200612902A - Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester - Google Patents

Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester

Info

Publication number
TW200612902A
TW200612902A TW094114589A TW94114589A TW200612902A TW 200612902 A TW200612902 A TW 200612902A TW 094114589 A TW094114589 A TW 094114589A TW 94114589 A TW94114589 A TW 94114589A TW 200612902 A TW200612902 A TW 200612902A
Authority
TW
Taiwan
Prior art keywords
cholesterol
lipase
agents
absorption
suppressing
Prior art date
Application number
TW094114589A
Other languages
English (en)
Inventor
Toshio Hayami
Hideyuki Kishida
Naoki Arai
Shinnichi Yokota
Kazuya Hamada
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of TW200612902A publication Critical patent/TW200612902A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094114589A 2004-05-13 2005-05-05 Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester TW200612902A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004143210 2004-05-13
JP2004271567 2004-09-17

Publications (1)

Publication Number Publication Date
TW200612902A true TW200612902A (en) 2006-05-01

Family

ID=35393981

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094114589A TW200612902A (en) 2004-05-13 2005-05-05 Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester

Country Status (3)

Country Link
JP (1) JPWO2005110400A1 (zh)
TW (1) TW200612902A (zh)
WO (1) WO2005110400A1 (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689081A (zh) * 2016-08-31 2019-04-26 釜山大学校产学协力团 局部肥胖治疗用组合物及包含其的微针
CN115925778A (zh) * 2022-12-13 2023-04-07 五邑大学 一种甘草次酸-十二烷-胆固醇化合物及其合成方法和应用
CN116322651A (zh) * 2020-10-07 2023-06-23 株式会社钟化 甲状腺素运载蛋白四聚体稳定化剂、以及甲状腺素运载蛋白淀粉样变性预防剂或进展抑制剂

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808333A (en) * 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation
US20080286254A1 (en) * 2007-05-17 2008-11-20 Kaneka Corporation Composition comprising licorice polyphenol
US20110123505A1 (en) 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
EP2234493A4 (en) * 2007-12-21 2011-05-25 Univ Cincinnati THERAPEUTIC USE OF CARBOXYLESTERLIPASE INHIBITORS
JP2011231057A (ja) * 2010-04-28 2011-11-17 Kao Corp セラミド産生促進剤
JP6236697B2 (ja) * 2012-12-27 2017-11-29 株式会社ゆふ・は 吸収材料及び、それを用いた石鹸
JP7535838B2 (ja) 2017-08-10 2024-08-19 小林製薬株式会社 脂質排泄促進剤
JP7602854B2 (ja) * 2017-08-10 2024-12-19 小林製薬株式会社 防風通聖散エキス
JP2021187801A (ja) * 2020-06-03 2021-12-13 小林製薬株式会社 脂質排泄促進剤
CN113598253A (zh) * 2021-07-14 2021-11-05 云南润攀生物科技有限公司 一种促进生酮作用和增加体脂肪分解的生酮草本茶
CN115736054B (zh) * 2022-12-05 2024-09-03 安徽农业大学 一种降糖降脂固体枸杞花茶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000226324A (ja) * 1998-11-30 2000-08-15 Kansai Koso Kk 清浄・清拭用及び化粧水用液剤組成物
IL138603A0 (en) * 2000-09-21 2001-10-31 Ready Made 37 1999 Ltd Licorice extract for use as a medicament
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
EP1440688A4 (en) * 2001-10-11 2005-11-30 Kaneka Corp PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND METHOD OF MANUFACTURING THE SAME
JP4191420B2 (ja) * 2002-03-26 2008-12-03 株式会社カネカ 甘草疎水性抽出物を含有してなる食用油脂組成物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689081A (zh) * 2016-08-31 2019-04-26 釜山大学校产学协力团 局部肥胖治疗用组合物及包含其的微针
CN109689081B (zh) * 2016-08-31 2022-12-16 Sn维亚股份有限公司 局部肥胖治疗用组合物及包含其的微针
CN116322651A (zh) * 2020-10-07 2023-06-23 株式会社钟化 甲状腺素运载蛋白四聚体稳定化剂、以及甲状腺素运载蛋白淀粉样变性预防剂或进展抑制剂
CN115925778A (zh) * 2022-12-13 2023-04-07 五邑大学 一种甘草次酸-十二烷-胆固醇化合物及其合成方法和应用

Also Published As

Publication number Publication date
WO2005110400A1 (ja) 2005-11-24
JPWO2005110400A1 (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
TW200612902A (en) Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester
MX2009007014A (es) Carne molida y composiciones analogas de carne que tienen mayores propiedades nutritivas.
ATE495674T1 (de) Fruchthaltige schokolade oder ähnliches
DE60229286D1 (de) Lebensmittel oder tierfutter enthaltend die knochengesundheit unterstützendes pflanzenextrakt aus amelanchier
WO2009010368A3 (en) Composition comprising bacteria and lecithin
WO2009047754A3 (en) Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
MX2009006342A (es) Composicion de complemento alimenticio para tratamiento de enfermedades oculares.
EA201070893A1 (ru) Способы и композиции для лечения заболеваний костей
TW200740379A (en) Nutrition for obese patients
EP1781107A4 (en) PHYTOPHARMACEUTICAL COMPOSITIONS FOR PREVENTING AND / OR TREATING CARDIOVASCULAR DISEASES AND PROCESS FOR PREPARING THEM
GB0615781D0 (en) Prebiotic composition
WO2008102017A3 (en) Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
ATE406169T1 (de) Verwendung von bananenextrakt zur behandlung von entzündlicher darmkrankheit
MX2007004879A (es) Proteccion de ingredientes de alimentos bioactivos por medio de encapsulacion.
WO2009024991A3 (en) Antiobese compositions containing holopteleλ integrifolia extracts
WO2005051290A3 (en) Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
CR8265A (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de enfermedades mediadas por cox-2
WO2011019210A3 (ko) 치아 시드 및 마카를 포함하는 건강보조식품, 사료, 약학 조성물 및 그 제조방법
MX2009014014A (es) Recubrimiento.
EP1548445A3 (en) Novel targets for obesity from fat tissue
BRPI0519901A2 (pt) extratos vegetais e métodos e usos
ATE417035T1 (de) Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen
MY139463A (en) Food or pet food composition containing plant extract from amelanchier for bone health
MX2024013203A (es) Composiciones farmaceuticas y nutraceuticas con una combinacion de aminoacidos y su uso en enfermedades caracterizadas por la acumulacion de lipidos en los tejidos.